Basilea Pharmaceutica AG: Basilea participates in public-private collaboration to tackle antibiotic resistance – Finanz Nachrichten

Ceftobiprole is a novel broad-spectrum anti-MRSA cephalosporin antibiotic for the potential first-line empiric treatment of severe multi-drug resistant bacterial infections. Available data demonstrate activity against a wide range of clinically-relevant …

Leave a Reply

Your email address will not be published.